Newsroom | 20129 results
Sorted by: Latest
-
Axcelead DDP and Superluminal Announce the Intent to Collaborate on Drug Discovery Targeting Specific Molecular Mechanisms, continuing a productive relationship
FUJISAWA, Japan & BOSTON--(BUSINESS WIRE)--Axcelead Drug Discovery Partners, Inc. (Axcelead DDP) and Superluminal Medicines, Inc. (Superluminal) announced the intention to collaborate on drug discovery targeting specific molecular mechanisms associated with challenging biological targets. The two companies have built a strong relationship through prior collaborations. Axcelead DDP provided high-quality in vivo pharmacological evaluations of proprietary compounds developed by Superluminal using...
-
ArrePath Announces Closing of Their Next Financing Round and Appointment of a New Board Chair
PRINCETON, N.J.--(BUSINESS WIRE)--ArrePath, a company applying its proprietary artificial intelligence and machine learning platform together with deep R&D technical expertise to address the challenge of best-in-class antibacterial drug discovery, announced several business updates. First, the company has raised the next round of financing to advance its pipeline and continue to expand the scope and capabilities of its discovery platform. The Boehringer Ingelheim Venture Fund led the financ...
-
ZEISS Vision Care US Names Healthcare Industry Veteran Gary Rosenblum as President and Chief Executive Officer
HEBRON, Ky.--(BUSINESS WIRE)--ZEISS Vision Care, one of the world’s leading manufacturers of eyeglass lenses and ophthalmic instruments, announced today that Gary Rosenblum has been named President and Chief Executive Officer of ZEISS Vision Care US, effective June 16, 2025. Rosenblum brings relevant senior leadership experience at Demant, Johnson & Johnson, Abbott and Pfizer to his new role. He succeeds Jens Boy, who has spent more than a decade driving the ZEISS Vision Care business in No...
-
TriSalus Life Sciences Announces Commencement of Exchange Offer and Consent Solicitation Relating to Series A Convertible Preferred Stock to Streamline Capital Structure
WESTMINSTER, Colo.--(BUSINESS WIRE)--TriSalus Life Sciences® Inc. (Nasdaq: TLSI), a company working to improve outcomes for patients with solid tumors by combining innovative drug delivery, current on-market therapeutics and immunotherapy (“TriSalus” or the “Company”), today announced that it has commenced an exchange offer and consent solicitation involving its Series A Convertible Preferred Stock (the “Preferred Stock”) identified in the Prospectus/Offer to Exchange (as defined below). TriSal...
-
Veradigm Provides 2025 Financial & Business Update
CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, is providing an update on commercial activity and estimated financial performance for the first quarter of 2025 compared to the prior year, details about its recent financing, and reaffirmation of its outlook for the 2025 fiscal year. “The year started on a positive note by closing deals with over $30 million in annual contract value in the first quarter of 2025, a 25 percent inc...
-
Seek Labs Maps Measles Virus with BioSeeker™, Opening the Door to First-Ever Programmable Antiviral Therapeutic Amid Global Outbreaks
SALT LAKE CITY--(BUSINESS WIRE)--Seek Labs, a biotech company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics, today announced the successful mapping of conserved therapeutic targets within the measles virus (MeV) genome using BioSeeker™, the company’s proprietary AI-powered discovery engine. Amid rising measles outbreaks worldwide, this breakthrough marks a foundational step toward developing the world’s first programmable...
-
LifePlus Establishes Global Clinical Validation for First-of-Its-Kind Non-Invasive Glucose and Cuffless BP Monitoring Device and Platform
SAN JOSE, Calif.--(BUSINESS WIRE)--LifePlus, a Silicon Valley startup redefining personal health monitoring, today announced the clinical validation of LifeLeaf®, the world’s first non-invasive and cuffless wearable for continuous glucose and blood pressure tracking. The device, tested in global multi-center trials including Mayo Clinic, AMCR Clinic – San Diego, CA, Cleveland Clinic – Abu Dhabi, and Hospital Sebarang Jaya – Penang, Malaysia, delivers real-time insights without needles, invasive...
-
Vitality unleashes Stanley the dachshund in the US following UK success
CHICAGO--(BUSINESS WIRE)--Vitality, a global leader in engagement and behavior change, has today announced the US debut of brand mascot, Stanley the dachshund, as part of a bold new marketing strategy, signaling its focus on brand awareness and redefining how people engage with their health across the US. Stanley, who first captured hearts in the UK ten years ago, embodies Vitality’s brand and core purpose of making people healthier, both to make health more accessible and relatable. Stanley no...
-
Kopin to Showcase Portfolio of Spatial Light Modulators and Microdisplays at Laser World of Photonics 2025
WESTBOROUGH, Mass.--(BUSINESS WIRE)--Kopin Corporation (NASDAQ: KOPN), a leading provider of application-specific optical systems and high-performance microdisplays for defense, training, enterprise, industrial, consumer and medical products, today announced will be presenting its range of cutting-edge spatial light modulators (SLMs) and microdisplays at this year’s Laser World of Photonics, taking place from June 24–27 at the Munich Trade Fair Center. Attendees can explore the latest advanceme...
-
Biodefense Industry Research 2025-2030 | Emerging Opportunities in the Development of AI-Powered Biosurveillance, Nanotech-Based Biosensors, and Predictive Health Analytics - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Biodefense Market by Technology, Product, Application, and Region - Global Forecast to 2030" report has been added to ResearchAndMarkets.com's offering. The biodefense market is estimated at USD 0.89 billion in 2025 and is projected to reach USD 1.81 billion by 2030 at a CAGR of 15.1%. Technological advancements and changing market conditions are the key drivers of the biodefense market. This report serves as a valuable resource for market leaders and newcomers in...